700 patients110,866 observations180 daysLIVE

Patient P-02223

Synthetic patientMETA-24 · Day 178 · 55–64 · M · baseline S20Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
13%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S20
  2. Day 14 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 22 HY-01 recommendedHydration Protocol HY-01
  4. Day 23 Patient acceptedStarted HY-01 in the companion
  5. Day 27 GI symptom burden −14% vs expectedHydration Protocol HY-01
  6. Day 33 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 14.

Primary contributors, last 14 days
  • GI instability-13
  • Inflammatory activity-13
  • Nutritional resilience+6
  • Treatment adherence-3
  • Toxicity-2

What helped?

  • Hydration Protocol HY-01Day 22
    Result: symptom burden −14%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
53 min
stable · -1.4 vs previous 14 d
Sleep duration
Wearable
6.7 h
stable · -0.1 vs previous 14 d
Energy level
Daily log
5.1/10
stable · +0.0 vs previous 14 d
Steps
Wearable
5,446
stable · +14 vs previous 14 d
GI burden
Companion
24.4/100
improving · -3.3 vs previous 14 d
Adherence
Companion
97.3 %
stable · +0.4 vs previous 14 d
Sleep quality
Wearable
44.8/100
stable · +0.4 vs previous 14 d
Glucose, CGM daily mean
CGM
135 mg/dL
stable · +1.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 64 from the failing basin, 31 from restoration.

Good elements to keep
  • Protein (supports)
    perturbation · steering +10.9
  • Hydration Protocol HY-01
    intervention · steering +9.2
  • Daily walks resumed
    perturbation · steering +3.3
  • Protein
    supporter · GI -5.7 next day
Main detractors to watch
  • Low butyrate capacity
    hidden · steering -17.5
  • Dietary fat load
    perturbation · steering -8.7
  • Low microbial diversity
    hidden · steering -7.7
  • Bacteroides fragilis elevated
    hidden · steering -7.4
  • Dietary fat load
    detractor · GI +4.6 next day
  • Ultra-processed food
    detractor · GI +4.1 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -5.7supporter · 95%
  • Dietary fat load
    +4.6detractor · 95%
  • Ultra-processed food
    +4.1detractor · 92%
  • Simple carbohydrates
    +4detractor · 74%
  • Caffeine
    +0.9no signal · 17%
  • Histamine load
    -0.7no signal · 15%
  • Alcohol
    -0.7no signal · 15%
  • Insoluble fibre
    +0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 60
    • MicrobiomeButyrate capacity 44/100
    • MicrobiomeF. prausnitzii depleted
  • Mucosal barrier integrity 30
    • MicrobiomeAkkermansia low → thinner mucus layer
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.6 · butyrate capacity 44/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
48 ms
Sleep
6.5 h
Steps
5,808
Resting HR
59 bpm
Daily log: GI score 24, nutritional resilience 60, adherence 97.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0203348%S06GI-04improved51
P-0233948%S03DT-01improved50
P-0253847%S02GI-04improved59
P-0230346%S15GI-04improved48
P-0239546%S12DT-01improved57
P-0203745%S04GI-04improved53
P-0245545%S09DT-01improved50
P-0223544%S14DT-01improved50
P-0247944%S13DT-01improved48
P-0264544%S02HY-01improved56
P-0212643%S16DT-01improved59
P-0227443%S15DT-01improved50